Companies / Surgery Partners, Inc.
Surgery Partners, Inc.
Nasdaq: SGRYCIK 1638833BRENTWOOD, TN
Financials · FY2017
Ownership
130.9M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 1.34% | 1,748,634 |
| 10%+ / strategic | 4.99% | 6,537,016 |
| Institutions | 113.84% | 149,032,587 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Evans Jason EricCEOChief Executive Officer | 0.70% | 920,386 |
Baldock JenniferChief Admin & Dev Officer | 0.25% | 326,474 |
Doherty David TChief Financial Officer | 0.17% | 221,679 |
Oppenheimer Justin RobertFormerCOO & National Group President | 0.09% | 120,259 |
Brittenham MarissaChief Strategy Officer | 0.07% | 94,196 |
Turner BrentDirector | 0.07% | 86,594 |
Burkhalter DanielleFormerChief Human Resources Officer | 0.06% | 76,864 |
Webb William TrentonFormerAmerican Group President | 0.06% | 74,249 |
Adlerz Clifford GDirector | 0.05% | 69,104 |
Hendrix Blair EDirector · 10% owner | 0.01% | 18,531 |
Institutional holders 192
View all →| Holder | Value | % of shares |
|---|---|---|
| $595.37M | 38.15% | |
| $161.40M | 10.34% | |
| $154.50M | 7.64% | |
| $121.94M | 7.81% | |
| $120.57M | 5.96% | |
| $116.89M | 5.78% | |
| $104.86M | 4.77% | |
| $101.58M | 5.02% | |
| $75.81M | 3.75% | |
| $49.09M | 3.15% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Evans Jason Eric CEO | Grant | Common Stock | $2.00M | +142K +21.39% | 804,423 0.61% of shares | low |
| Mar 5, 2026 | Evans Jason Eric CEO | Grant | Common Stock | $1.92M | +136K +16.95% | 940,786 0.72% of shares | low |
| Jan 13, 2026 | Oppenheimer Justin Robert Executive | Grant | Common Stock | $1.25M | +78K | 77,736 0.06% of shares | low |
| Mar 5, 2026 | Doherty David T Executive | Grant | Common Stock | $800.0K | +57K +63.85% | 145,500 0.11% of shares | low |
| Mar 5, 2026 | Doherty David T Executive | Grant | Common Stock | $769.6K | +55K +37.49% | 200,045 0.15% of shares | low |
| Mar 5, 2026 | Baldock Jennifer Executive | Grant | Common Stock | $600.0K | +43K +18.01% | 278,570 0.21% of shares | low |
| Mar 5, 2026 | Oppenheimer Justin Robert Executive | Grant | Common Stock | $600.0K | +43K +54.70% | 120,259 0.09% of shares | low |
| Mar 5, 2026 | Baldock Jennifer Executive | Grant | Common Stock | $577.2K | +41K +14.69% | 319,479 0.24% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Pentwater Capital Management LP | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SGRY | — | 86881A100 |